The Carbon to Value Initiative kicked off last week at Greentown Houston. Photo via GreentownLabs.com

A carbon innovation initiative in collaboration with Greentown Houston has named its new cohort.

The Carbon to Value Initiative (C2V Initiative) — a collaboration between NYU Tandon School of Engineering's Urban Future Lab (UFL), Greentown Labs, and Fraunhofer USA — has named nine startup participants for the fourth year of its carbontech accelerator program.

"Once again, the C2V Initiative has been able to select some of the most promising carbontech startups through a very competitive process with a 7 percent acceptance rate," Frederic Clerc, director of the C2V Initiative and interim managing director of UFL, says in a news release. "The diversity of this cohort, in its technologies, products, geographies, and stages, makes it an amazing snapshot of the rapidly evolving carbontech innovation landscape."

The cohort was selected from over a hundred applications from nearly 30 countries. In the six-month program, the nine companies gain access to the C2V Initiative's Carbontech Leadership Council, an invitation-only group of corporate, nonprofit, and government leaders who provide commercialization opportunities and identify avenues for technology validation, testing, and demonstration.

The year four cohort, according to the release, includes:

  • Ardent, from New Castle, Delaware, is a process technology company that is developing membrane-based solutions for point-source carbon capture and other chemical separations.
  • CarbonBlue, from Haifa, Israel, develops a chemical process that mineralizes and extracts CO2 from water, which then reabsorbs more atmospheric CO2.
  • MacroCycle, from Somerville, Massachusetts, develops a chemical recycling process to turn polyethylene terephthalate (PET) and polyester-fiber waste into "virgin-grade" plastics.
  • Maple Materials, from Richmond, California, develops an electrolysis process to convert CO2 into graphite and oxygen.
  • Oxylus Energy, from New Haven, Connecticut, develops a direct electrochemical process to convert CO2 into fuels and chemical feedstocks, such as methanol.
  • Phlair, from Munich, Germany, develops a renewable-energy-powered Direct Air Capture (DAC) system using an electrochemical process for acid and base generation.
  • Secant Fuel, from Montreal, Quebec, Canada, develops a one-step electrocatalytic process that converts flue gas into syngas.
  • RenewCO2, from Somerset, New Jersey, is developing an electrochemical process to convert CO2 into fuels and chemicals, such as sustainable aviation fuel (SAF) or propylene glycol.
  • Seabound, from London, England, builds carbon-capture equipment for new and existing ships.

"The depth and breadth of carbontech innovations represented in this applicant pool speaks volumes to this growing and dynamic industry around the world," adds Kevin Dutt, Interim CEO of Greentown Labs. "We're eager to support these nine impressive companies as they progress through this program and look forward to seeing how they engage with the CLC now and into the future."

The C2V Initiative kicked off at a public event on Sept. 19 at Greentown Houston and via livestream.

------

This article originally ran on EnergyCapital.

A new six-month accelerator program is looking to move the needle on the energy transition. Photo via greentownlabs.com

Houston organizations team up to accelerate startups with low-carbon solutions

greentown hou

Attention, innovators: A new initiative in Houston is searching for startups whose offerings can help reduce global carbon emissions.

The Low-Carbon Hydrogen Accelerator is a partnership involving Greentown Labs, the Electric Power Research Institute, Shell Oil, the City of Houston, and New York University's Urban Future Lab. The accelerator is seeking applications from startups that are advancing low-carbon hydrogen production, enhancing hydrogen storage and distribution, or providing business models for management of hydrogen supply chains. Applications are due February 9, 2022.

"If we can improve the devices and processes that will be used to make, transport, and store clean hydrogen in the future, it can become a cost-competitive fuel. At the same time, these advances can improve the capacity factor of renewable generation, producing multiple economic and climate benefits," Pat Sapinsley, managing director of cleantech initiatives at the Urban Future Lab, says in a news release.

The six-month accelerator will enable startups to collaborate with the Electric Power Research Institute, utilities, and Shell on tech development, feasibility studies, pilot projects, and other low-carbon efforts.

The institute and Shell will provide startups two routes within the accelerate: a path for validation of their technology and a path for demonstration of their technology.

"Accelerating low-carbon hydrogen technologies is essential to achieving global net-zero targets by 2050," says Neva Espinoza, the institute's vice president of energy supply and low-carbon resources.

Shell foresees hydrogen playing a bigger role in hard-to-decarbonize sectors such as heavy-duty trucking, marine, aviation, chemicals, steel, and cement. Julie Ferland, vice president of innovation excellence at Houston-based Shell Oil, says programs such as the new accelerator will be critical to fostering low-carbon energy.

Earlier this year, after visiting Greentown Labs' Houston location, U.S. Energy Secretary Jennifer Granholm and the U.S. Department of Energy launched the Hydrogen Energy Earthshot to reduce the cost of clean hydrogen by 80 percent to $1 per kilogram by 2030.

"As the Energy Capital of the World, I believe it is our responsibility to continue Houston's legacy of energy innovation and develop the technologies and practices needed to decarbonize the global energy sector," Houston Mayor Sylvester Turner says. "Houston has the skilled workforce and infrastructure to develop clean hydrogen at scale, and Greentown Labs' Low-Carbon Hydrogen Accelerator is a great example of the kind of partnerships we need to make it happen."

Greentown Labs is the largest climatech startup incubator in North America. The Somerville, Massachusetts-based incubator recently opened its Houston location.

Houston-based Cemvita Factory, which biomimics photosynthesis to turn carbon emissions into feedstock, has been selected for a new international accelerator. Photo courtesy of Cemvita Factory

Houston startup selected for international carbontech accelerator

the future of climatech

A new international accelerator focused on the commercialization of carbontech has announced its new cohort — and one Houston-based company has made the cut.

Cemvita Factory has been accepted into the Carbon to Value Initiative, a recently launched accelerator supported by The Urban Future Lab at the NYU Tandon School of Engineering, Greentown Labs, and Fraunhofer USA. The program is focused on supporting companies with technologies that capture, convert, and store carbon dioxide (CO₂) into valuable end products or services, according to a news release.

"In addition to being absolutely necessary to stave off dangerous climate impacts, carbontech innovations represent a potential $3 trillion market opportunity," says Pat Sapinsley, managing director at the Urban Future Lab, in the news release. "We are excited to welcome 10 startups, each proposing different business models and technology innovations to realize that opportunity."

Cemvita Factory, which was founded by siblings Tara and Moji Karimi in 2017, has created a way to biomimic photosynthesis to take CO2 and turn it into something usable for its energy clients, like feedstocks. Cemvita has 30 different molecules its technology can produce and works with the likes of BHP, Oxy, and more.

"We are excited to represent Houston in the first cohort for the Carbon to Value Initiative," Moji Karimi tells InnovationMap. "We want to send a message that Houston is not just the Oil and Gas capital of the world, but also the center of gravity for a sustainable Energy Transition."The C2V Initiative selected 10 startups out of over 130 applications from 26 countries. The cohort has technologies ranging from carbon utilization product and process innovations to carbon capture and carbon sequestration solutions.

Cemvita isn't alone in repping the Lone Star State. San Antonio-based CarbonFree, which has commercial technologies that capture and convert industrial CO2 emissions into minerals for sale or storage, also made the cohort.

The other eight non-Texas companies are:

  • Air Company, based in New York City, transforms CO2 into high-purity alcohols that can be used in spirits, sanitizers, and a variety of consumer industries.
  • Reykjavík, Iceland-based Carbfix provides a natural and permanent carbon storage solution by turning CO2 into stone underground.
  • CarbonQuest, based in New York City, provides decarbonization technologies and solutions for buildings with a focus on modular carbon capture.
  • Toronto, Canada-based CERT converts CO2 to chemicals such as ethylene via electrolysis.
  • Made of Air, based in Berlin, Germany creates drop-in ready, durable thermoplastics using carbon captured by biomass.
  • Oakland, California-based Mars Materials develops a new pathway for carbon fiber production using CO2 as a raw material.
  • San Francisco-based Patch is a platform for negative emissions.
  • Planetary Hydrogen, based in Dartmouth, Canada, combines hydrogen production with CO2 sequestration via ocean air capture.

The program kicks off at a virtual event on May 6 from 3-5 p.m. The six-month program will provide its cohort with a customized curriculum, hands-on mentorship, and knowledge-sharing sessions with C2V Initiative's Carbontech Leadership Council — an invitation-only group of international corporate, academic, and government thought leaders.

The cohort will also receive complimentary membership and access to the Greentown Labs community, which includes is recently opened facility in Houston.

"We know that to effectively address the climate crisis and mitigate the effects of climate change, we need to rapidly scale and deploy carbontech solutions to accelerate the energy transition," says Emily Reichert, CEO of Greentown Labs. "We're proud to support these startups from all over the world and look forward to the collaborations that will spark among the startups and our CLC members."

Listen to Cemvita Factory's episode of the Houston Innovators Podcast below.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Baylor College of Medicine launches VC fund to invest in biotech startups

fresh funding

Houston’s Baylor College of Medicine just unveiled a new venture capital fund that backs early-stage biotech startups—and it’s already made its first investment.

BCM Legacy Fund I, funded by philanthropies, invested an undisclosed amount in Houston biotech startup Nemea Therapeutics. Nemea, a spinout of the Baylor College of Medicine and Germany’s Lead Discovery Center, is developing an oral drug to treat metastatic triple-negative breast cancer that no longer responds to currently available therapies.

This type of aggressive cancer spreads from the breast to other areas of the body, such as the bones, liver, lungs or brain. Roughly 38,000 to 57,000 Americans are diagnosed each year with metastatic triple-negative breast cancer. One study showed about half of patients survive past the one-year mark following diagnosis and about one-third survive two years.

“Baylor College of Medicine’s laboratories produce discoveries with the potential to change patients’ lives, and too many of them stall where academic funding ends and private investment has not yet begun,” Dr. Jakub Tolar, president, CEO and executive dean of the Baylor College of Medicine, said in a press release. “The BCM Legacy Fund fills that gap, giving our scientists a path to advance their discoveries to patients.”

The National Institutes of Health awards more than $36 billion per year for biomedical research in the U.S., Baylor said. But some biomedical discoveries “never leave the starting line because they don’t yet fit the economics of venture capital,” the college said.

“The forefront of a new model”

The BCM Legacy Fund aggregates philanthropic capital from private foundations and donor-advised funds. It then invests in startups so they can move beyond that starting line and into later-stage investment rounds. The Greater Houston Community Foundation is the fund’s philanthropic partner.

“It’s exciting to be on the forefront of a new model for philanthropic capital,” said Houston entrepreneur and investor Burton Hanson, managing partner of the fund.

“Not only do we hope to solve a real problem by advancing these therapies to the patients who need them most, but we also hope this model will inspire others in the city and beyond toward philanthropic creativity and a posture of ‘I sacrifice; we win.’”

The fund expects to invest in about 15 early-stage startups over a five-year span. Baylor declined to divulge the amount of money in the fund and the size of the investment in Nemea.

Nemea’s “world-class chemistry”

Hanson oversees the Baylor fund alongside Chicago investor Steve Lehmann, who led the University of Chicago’s Innovation Fund.

Lehmann said Nemea, the fund’s first portfolio company, “has world-class chemistry, Baylor biology, and patients with no good options. Our job is to fund the experiments that carry it to the next handoff, so that industry and later-stage investors can take it from there.”

Based at Houston’s massive Texas Medical Center, Nemea plans to start clinical trials next year in collaboration with Baylor’s Lester and Sue Smith Breast Center.

Nemea previously received $9 million from the Lead Discovery Center and a $1.6 million grant from Baylor. Last year, the startup said it was seeking $25 million to $30 million in seed and Series A funding.

Debra McCoy of Houston, a former managing director at BlackRock and former partner at Bain & Co., and Paul Thomas, co-founder and CEO of Spring-based benefits manager Luscinia Health, sit on the Baylor fund’s governing board. Dr. Paul Klotman, former president, CEO and executive dean of Baylor, is a senior strategic adviser.

How does the fund find investment targets?

The Baylor Legacy Fund relies on two tools to help unearth early-stage biotech startups:

  • High-resolution “innovation maps” of research institutions. These maps surface hidden clusters of innovation, identify rising-star researchers and tie pockets of “innovation supply” at Baylor to areas of “innovation demand” in biotech.
  • AI-enhanced due diligence. AI agents assist with due diligence of early-stage biotech startups. The fund says the platform “distills the frameworks we’ve developed over a decade of teaching and investing into a flexible … diligence environment.”

MD Anderson unveils $3.4B expansion with two new Houston cancer care facilities

major expansion

The cutting edge of cancer-fighting technology and science is getting even sharper after MD Anderson announced last week that it will open two new facilities in the Texas Medical Center within the next five years. Inspiration Tower and Prism will expand MD Anderson’s annual patient load in the TMC to 250,000 annually and will incorporate a variety of new techniques.

The $3.4 billion project will add 2 million square feet to MD Anderson's TMC footprint, bringing its total campus size to 22 million square feet by 2032. Located at the corner of Fannin Street and Holcombe Boulevard, the cancer center says the two new facilities will serve as its new "front door" to the TMC.

“Every detail of these buildings, from the technology to the treatment rooms, was designed around our patients who will receive their care in them and our employees who will work in them. The facilities will serve as a physical representation of hope for the patients and their families who will walk through the doors,” Dr. Jeffrey E. Lee, president ad interim of UT MD Anderson, said in a news release. “Inspiration Tower and Prism are the future of cancer care, and we are grateful for the longstanding support and guidance we’ve received from the UT System Board of Regents to bring these projects to life. These facilities are part of the most impactful capital expansion in UT MD Anderson’s history.”

Prism is especially exciting as it will represent fully half of the linear accelerator treatment in the TMC. Linear accelerator is a radiation treatment that uses magnetically charged fields to deliver targeted external radiation therapy, like shooting cancer with a rail gun. The treatment is safer and has fewer side effects than older radiation treatments.

In addition, Prism will contain 12 MRI machines, four CT scanners, two PET-CT units, 18 radiation vaults and seven radiation simulators. Patient comfort has also been put at a premium with multiple gardens and roof overlooks.

“Every patient we treat deserves an environment that reflects the excellence of the care they receive at UT MD Anderson,” Chris McKee, executive vice president and chief strategy officer at UT MD Anderson, added in the release. “Our new facilities will be innovative, agile, adaptable and beautiful, and they will allow us to care for more patients, more effectively – in an environment that enhances healing and well-being. We are building for our future and for every patient who will be counting on us.”

Prism is slated to open in 2030.

Inspiration Tower will have 25 floors of surgical, diagnostic, and treatment services. At 1.4 million square feet, it’s currently expected to be the largest cancer-specific treatment facility in the United States. The tower will be divided into units for specific types of cancer, making it easy to integrate the advancing research being done all over Houston.

Like Prism, Inspiration Tower is specifically designed to offer comfort and reassurance, with more garden space, terraces, and beautiful scenery to ease patient distress. It is expected to open in 2032.

Tesla will pull the plug on Cybertruck production at Texas factory in 2027

Tesla Talk

Tesla’s Cybertruck, the hulking, stainless-steel pickup that inspired devotion and derision with its science-fiction looks, will cease production next year.

CEO Elon Musk announced the model’s demise Friday, November 6, with a curt post on X, his social media site, simply noting production of the vehicle “will be winding down” around the middle of 2027 at its facility outside Austin, Texas. Musk said the move was to allow increased production of its Cybercab robotaxi.

For the Cybertruck, a pet project of Musk who insisted it was Tesla’s best product, it marks an unceremonious end to one of the auto industry’s most ballyhooed debuts.

“Few vehicles in history have generated as much attention,” said Armen Hareyan, whose Torque News site covers autos. “The Cybertruck became a cultural symbol – loved, mocked and impossible to ignore.”

The Cybertruck rolled onto the scene in a dramatic unveiling in 2019, when a Tesla designer hurled a metal ball at the vehicle to demonstrate its supposedly unbreakable glass, only to see it shatter. He repeated the stunt on another window of the truck only to shatter that one, too.

Even as some critics scoffed, Musk was steadfast.

“I just wanted to make a futuristic battle tank — something that looks like it could come out of ‘Blade Runner’ or ‘Aliens’ or something like that but was also highly functional,” he told Automotive News. He called it “a better sports car than a Porsche 911” and “a better truck than an F-150.”

It struck some as the perfect vehicular reflection of the brash, convention-busting Musk.

“A really controversial vehicle unveiled by a controversial individual into a market where none of the electric trucks have been able to really capture demand,” said Spencer Penn, a former Tesla executive who left the company before the Cybertruck’s launch and now heads software developer LightSource.

Penn remembered watching the unveiling and feeling initially revolted by the sight of the Cybertruck, calling its appearance “madness.” But the more he looked at it, the more his opinion changed. He signed up for a pre-sale reservation, though ended up not getting a Cybertruck when Musk’s promises of a price tag under $40,000 went unmet and the first trucks sold for double or more. Penn called the Cybertruck part of Tesla’s adventurous spirit that drives innovation.

“Some of these bets work and some of these bets don’t,” he said.

While the decision to end Cybertruck production may be driven by sales realities, it's also a reflection of Tesla’s shift to autonomous vehicles, on which Musk is betting the company’s future.

Musk once forecast he’d make 250,000 Cybertrucks a year. Kelley Blue Book estimated Tesla sold just 20,237 of the vehicles last year, down about half from the year prior. Sales through the end of September this year were down another 28%, according to Kelley Blue Book.

If the imposing, sharp-angled, dystopian appearance of the Cybertruck weren’t enough to turn many potential buyers away, Musk did so himself by allying with a panoply of right-wing figures, most notably U.S. President Donald Trump. He alienated some customers as his image morphed from eccentric innovator to polarizing force trading his billions for political influence.

Once-passionate Tesla drivers rushed to sell off their cars, or slapped stickers on the bumper declaring, “I bought this before Elon went crazy.” Organizers staged demonstrations outside Tesla showrooms and urged investors to dump shares of the company’s stock. Anger spilled into violence, with Molotov cocktails hurled at Tesla vehicles, charging stations set ablaze, and dealerships covered in graffiti.

Lovers of the Cybertruck became targets, too, subjected to shouts of “Nazi!” and extended middle fingers.

Ross Blankenship is one of them. When he first laid eyes on the Cybertruck, he felt transported to a world from his childhood, when he would play “Halo,” the sci-fi video game. He had to have it.

“I had that sort of child in me wanting to be part of something cool that would change the future of automotive,” Blankenship said in a call from his Cybertruck as he drove through Sunnyside, Colorado. Even as Blankenship found he agreed with Musk on politics, he hated seeing a vehicle he loved turned into a political symbol. “I never bought it for any other reason than the fascination with the future technology of trucks … so that was a little heartbreaking.”

He would buy another Cybertruck again in a heartbeat, calling its end “a sad moment.”